Condition: OPA1 Gene Mutation · Optic Atrophy, Autosomal Dominant · Sponsor: Ludwig-Maximilians - University of Munich
This prospective, monocenter, non-interventional observational study investigates the natural history as well as the clinical and genetic spectrum of OPA1-associated autosomal dominant optic atrophy. Participants will undergo standardized ophthalmic and functional assessments, including visual acuity testing, visual field testing, color vision and contrast sensitivity testing, optical coherence tomography, retinal flavoprotein fluorescence imaging, and video-oculography-based ocular motor and pupillary measurements. The study aims to characterize disease severity and progression over time and to identify structural, metabolic, and functional biomarkers that may serve as clinical endpoints for future therapeutic studies.
This description comes directly from the study's public registry record.
Sarah Marxsen · +49 89 4400 53770 · sarah.marxsen@med.uni-muenchen.de
Ursula Reinstein, Dr. med. vet. · ursula.reinstein@med.uni-muenchen.de
Always discuss trial participation with your own doctor first.
| Department of Ophthalmology, LMU University Hospital, LMU Medizin, Ludwig-Maximilians-Universität München | Munich, Bavaria, Germany | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07729982